Seniors target of N.Y. safe sex campaign

Jul 03, 2007

Senior centers across New York recently began receiving free condoms as city officials have refocused their safe sex efforts to include local older citizens.

In an attempt to limit the spread of the human immunodeficiency virus in the city, local health officials have begun visiting senior centers to offer educational seminars and free prophylactics, the New York Post said Monday.

Department for the Aging commissioner Edwin Mendez-Santiago, whose group is helping to coordinate the senior-based effort, said the elderly represent an actual at-risk group.

"It's more than just a distribution of condoms. We were looking at the issue of HIV/AIDS in the above-50 population," he said.

"We also were concerned of the need to educate the community at large," Mendez-Santiago added. "We still face ageism and ... the assumption that older adults are not sexually active. So they can take precautions, particularly around safe sex."

The Post said 100 New York senior centers have already been given the health-based items and 225 others should soon be given similar educational materials.

Copyright 2007 by United Press International

Explore further: Amgen misses 1Q views as higher costs cut profit

add to favorites email to friend print save as pdf

Related Stories

Thanks to geotagged photos, are you sharing too much?

Feb 17, 2014

Whipping out your smartphone to snap and post online pictures of yourself and your kids relaxing at home - or perhaps that pricey new TV you just hung on your rec-room wall - is like throwing chum to a sea of hungry sharks.

Recommended for you

Amgen misses 1Q views as higher costs cut profit

Apr 22, 2014

Despite higher sales, biotech drugmaker Amgen's first-quarter profit fell 25 percent as production and research costs rose sharply, while the year-ago quarter enjoyed a tax benefit. The company badly missed ...

Valeant, Ackman make $45.6B Allergan bid

Apr 22, 2014

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion.

User comments : 0

More news stories